Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
T. N. H. Nguyen, L. Horowitz, T. Krilov, E. Lockhart, H. L. Kenerson, R. S. Yeung, N. Arroyo-Curras, A. Folch
Science Advances · Sep 6, 2024Peer-reviewedBioengineering
L. F. Horowitz, R. A. Rodriguez-Mias, M. Chang, S. Zhu, Y. Tang, A. Locke, N. R. Gottshall, I. Stepanov, C. Stiles, M. Yeung, T. N. Nguyen, E. J. Lockhart, C. Ahls, E. Wayne, W. Wei, , A. Folch
The paper develops a microscale ex vivo cancer model using tumor cuboids that retain a complex tumor microenvironment, enabling drug and immunotherapy testing.
bioRxiv · Mar 22, 2024 · PreprintCancer Biology
I. Stepanov, N. R. Gottshall, A. Ahmadianyazdi, D. Sinha, E. Lockhart, T. N. Nguyen, S. Hassan, L. Horowitz, R. Yeung, T. S. Gujral, A. Folch
This paper presents a low-cost robotic platform for manipulating live microtissues to enable cancer drug testing using patient biopsies on 384-well plates.
bioRxiv · Mar 21, 2024Bioengineering
E. Lockhart, L. F. Horowitz, C. Lim, T. Nguyen, M. Mehrabi, T. Gujral, A. Folch
The paper introduces a 96-well microfluidic device for testing drug responses in live tumor cuboids, preserving the tumor microenvironment for personalized oncology applications.
bioRxiv · Jul 7, 2022 · PreprintBioengineering
A. D. Rodriguez, L. F. Horowitz, K. Castro, H. Kenerson, N. Bhattacharjee, G. Gandhe, A. Raman, R. J. Monnat, R. S. Yeung, R. C. Rostomily, A. Folch
This paper develops a microfluidic platform for testing cancer drugs on intact tumor slices to improve drug response assessment in precision oncology.
bioRxiv · Mar 2, 2020Bioengineering
L. F. Horowitz, A. D. Rodriguez, Z. Dereli-Korkut, R. Lin, K. Castro, A. Mikheev, R. J. Monnat, A. Folch, R. C. Rostomily
This paper develops a microfluidic platform for rapid, multiplexed drug testing of cancer slices to guide personalized therapy.
bioRxiv · Feb 25, 2020Bioengineering